Clinical Trial Update: Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing TIMP-GLIA for celiac disease, including safety, pharmacodynamics, efficacy, and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• TIMP-GLIA

Snippet

Sponsor: Takeda | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-08-12